Latest news
Imugene (ASX:IMU) Bets on Off-the-Shelf CAR-T as Fresh Capital Buys Time for Azer-cel - KalkineKalkine · Fri, 31 Jul 2026 10:13:00 GMTBMS and Gilead rule in the CAR-T space. Off-the-shelf developers aren’t trying to change that. - Pharma VoicePharma Voice · Wed, 29 Jul 2026 07:00:00 GMTInside ImvivaBio's Trial For Off-The-Shelf CAR-T Strategy For Aggressive T-Cell Malignancies - Clinical LeaderClinical Leader · Tue, 28 Jul 2026 07:44:56 GMTThis Week’s CGT News: Off-the-Shelf CAR T Tackles Kidney Cancer - The Medicine MakerThe Medicine Maker · Mon, 27 Jul 2026 10:47:05 GMT